ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

OPK Opko Health Inc

1.3299
0.0299 (2.30%)
07 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Opko Health Inc OPK 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.0299 2.30% 1.3299 07:58:50
개장가 저가 고가 종가 전일 종가
1.29 1.29 1.34 1.32 1.30
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
03/05/202421:00GLOBEOPKO Health to Report First Quarter 2024 Financial Results..
28/03/202421:00PRNUSLabcorp Announces Acquisition of Select Assets of..
20/03/202421:00GLOBEEntera Bio Announces Robust Pharmacokinetic Data for..
08/03/202406:02EDGAR2Form ARS - Annual Report to Security Holders
05/03/202422:52GLOBEAIDS Clinical Trial Group Presents Results from Phase 1..
02/03/202406:05EDGAR2Form NT 10-K - Notification of inability to timely file Form..
28/02/202423:31PRNUSNextPlat Opens OPKO Health-Branded Storefront on Alibaba's..
28/02/202406:07EDGAR2Form 8-K - Current report
28/02/202406:05GLOBEOPKO Health Reports Fourth Quarter 2023 Business Highlights..
23/02/202406:05GLOBEOPKO Health to Report Fourth Quarter 2023 Financial Results..
17/02/202406:53EDGAR2Form PRE 14A - Other preliminary proxy statements
10/02/202406:07EDGAR2Form 8-K - Current report
05/02/202422:09PRNUSNextPlat Receives Initial Approvals to Launch OPKO..
30/01/202405:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/01/202406:15EDGAR2Form SC 13D/A - General statement of acquisition of..
25/01/202406:00EDGAR2Form 8-K - Current report
18/01/202407:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202407:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202407:09EDGAR2Form 8-K - Current report
10/01/202406:05GLOBEOPKO Health Announces Closing of Private Offering of $230..
08/01/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/01/202422:00GLOBEOPKO Health to Present at the 42nd Annual J.P. Morgan..
06/01/202407:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202406:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202403:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202402:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202421:00EDGAR2Form 8-K - Current report
05/01/202413:31GLOBEOPKO Health Announces Pricing of Private Offering of $200..
04/01/202407:05GLOBEOPKO Health Announces Private Offering of Convertible Senior..
28/11/202321:00PRNUSBioReference Health and Prognos Health Collaborate to..
13/11/202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202320:45PRNUSBioReference® Signs On as the First Laboratory to Use..
07/11/202306:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:06EDGAR2Form 8-K - Current report
07/11/202306:05GLOBEOPKO Health Reports Third Quarter 2023 Business Highlights..
02/11/202323:00GLOBENew Clinical Data on OPKO Health’s RAYALDEE® (ER..
01/11/202305:08EDGAR2Form 8-K/A - Current report: [Amend]
31/10/202321:00GLOBEOPKO Health to Report Third Quarter 2023 Financial Results..
26/10/202305:25GLOBEOPKO Health to Present New Clinical Data on Rayaldee (ER..
29/09/202306:10DJNModeX Therapeutics Awarded Contract to Address Public Health..
29/09/202305:09EDGAR2Form 8-K - Current report
29/09/202305:08GLOBEModeX Therapeutics Secures BARDA Contract to Develop Novel..
12/09/202321:30GLOBEEntera Bio Announces Collaboration with OPKO Biologics to..
04/08/202305:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/08/202305:07EDGAR2Form 8-K - Current report
04/08/202305:05GLOBEOPKO Health Reports Second Quarter 2023 Business Highlights..
26/07/202305:05GLOBEOPKO Health to Report Second Quarter 2023 Financial Results..
01/07/202305:10EDGAR2Form 8-K - Current report
28/06/202319:45BWFDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly..

최근 히스토리

Delayed Upgrade Clock